Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMPS
2276
Compass Pathways
CMPS
$1.86B
| $1.47M | ﹤0.01% |
182,900
-34,468
| -16% | -$346K |
|
2277
Norwood Financial Corp
NWFL
$376M
| $1.47M | ﹤0.01% |
43,925
-9,812
| -18% | -$297K |
|
|
FGH
2278
DELISTED
FG Group Holdings Inc.
FGH
| $1.47M | ﹤0.01% |
559,430
-42,571
| -7% | -$103K |
|
|
FPI
2279
Farmland Partners
FPI
$433M
| $1.46M | ﹤0.01% |
+117,300
| New | +$1.55M |
|
2280
GXO Logistics
GXO
$5.59B
| $1.46M | ﹤0.01% |
34,200
-220,800
| -87% | -$8.86M |
|
|
GMS
2281
DELISTED
GMS Inc
GMS
| $1.46M | ﹤0.01% |
29,300
-89,700
| -75% | -$4.3M |
|
2282
NBT Bancorp
NBTB
$2.78B
| $1.46M | ﹤0.01% |
+33,500
| New | +$1.48M |
|
2283
nVent Electric
NVT
$27.7B
| $1.45M | ﹤0.01% |
37,800
+30,200
| +397% | +$1.12M |
|
|
PVBC
2284
DELISTED
Provident Bancorp
PVBC
| $1.45M | ﹤0.01% |
199,072
+99,192
| +99% | +$1.01M |
|
2285
Verra Mobility
VRRM
$717M
| $1.45M | ﹤0.01% |
+104,800
| New | +$1.59M |
|
2286
Aspen Aerogels
ASPN
$485M
| $1.45M | ﹤0.01% |
122,700
-37,500
| -23% | -$429K |
|
|
CAN
2287
Canaan Creative
CAN
$171M
| $1.45M | ﹤0.01% |
702,637
+533,396
| +315% | +$1.48M |
|
2288
Quanterix
QTRX
$122M
| $1.45M | ﹤0.01% |
104,400
+4,000
| +4% | +$46K |
|
2289
Enterprise Financial Services Corp
EFSC
$2.4B
| $1.45M | ﹤0.01% |
29,504
+6,004
| +26% | +$298K |
|
2290
Standard Motor Products
SMP
$870M
| $1.44M | ﹤0.01% |
41,500
-45,900
| -53% | -$1.68M |
|
2291
Armstrong World Industries
AWI
$7.7B
| $1.43M | ﹤0.01% |
+20,900
| New | +$1.58M |
|
2292
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$3.09B
| $1.43M | ﹤0.01% |
+64,900
| New | +$1.68M |
|
2293
Avita Medical
RCEL
$243M
| $1.43M | ﹤0.01% |
216,312
-22,268
| -9% | -$133K |
|
2294
Rackspace Technology
RXT
$1.07B
| $1.43M | ﹤0.01% |
483,700
+191,700
| +66% | +$810K |
|
2295
Harte-Hanks
HHS
$31.9M
| $1.43M | ﹤0.01% |
122,000
-59,274
| -33% | -$656K |
|
2296
Frequency Electronics
FEIM
$863M
| $1.43M | ﹤0.01% |
202,161
-15,900
| -7% | -$86.4K |
|
|
PMD
2297
DELISTED
Psychemedics Corporation
PMD
| $1.43M | ﹤0.01% |
290,463
-15,700
| -5% | -$92.6K |
|
|
AMK
2298
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $1.42M | ﹤0.01% |
61,800
+28,900
| +88% | +$637K |
|
2299
Acco Brands
ACCO
$401M
| $1.42M | ﹤0.01% |
253,347
+34,100
| +16% | +$177K |
|
2300
Red Robin
RRGB
$192M
| $1.42M | ﹤0.01% |
253,723
+20,057
| +9% | +$149K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 522 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 522 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.